1998
Predictors of differential response to clozapine and haloperidol
Rosenheck R, Lawson W, Crayton J, Cramer J, Xu W, Thomas J, Stolar M, Charney D, Schizophrenia F. Predictors of differential response to clozapine and haloperidol. Biological Psychiatry 1998, 44: 475-482. PMID: 9777179, DOI: 10.1016/s0006-3223(98)00117-6.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAntipsychotic AgentsClozapineDouble-Blind MethodDrug ResistanceFemaleHaloperidolHumansMalePsychiatric Status Rating ScalesQuality of LifeRacial GroupsSchizophreniaSchizophrenic PsychologySocial SupportTreatment OutcomeUnited StatesUnited States Department of Veterans AffairsConceptsQuality of lifeThree-month outcomeOnset of schizophreniaSeverity of symptomsGreater symptom reductionGreater improvementRefractory patientsRefractory schizophreniaClozapine treatmentHospital daysClinical predictorsExtrapyramidal symptomsHospitalized patientsClinical trialsBaseline predictorsSample patientsSide effectsSymptom reductionClozapinePatientsSymptomsHigher symptomsHigh levelsHaloperidolMultiple regression analysis
1997
HOMELESS MENTALLY ILL VETERANS
Rosenheck R, Leda C, Frisman L, Gallup P. HOMELESS MENTALLY ILL VETERANS. American Journal Of Orthopsychiatry 1997, 67: 632-638. PMID: 9361869, DOI: 10.1037/h0080260.Peer-Reviewed Original ResearchImpact of representative payees on substance use by homeless persons with serious mental illness
Rosenheck R, Lam J, Randolph F. Impact of representative payees on substance use by homeless persons with serious mental illness. Psychiatric Services 1997, 48: 800-806. PMID: 9175189, DOI: 10.1176/ps.48.6.800.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismCase ManagementDiagnosis, Dual (Psychiatry)Eligibility DeterminationFemaleHumansIll-Housed PersonsIllicit DrugsLegal GuardiansMaleMental DisordersMiddle AgedMotivationPatient Care TeamPatient DropoutsPsychotropic DrugsPublic AssistanceSocial SecuritySubstance Abuse DetectionSubstance-Related DisordersTreatment OutcomeUnited StatesConceptsSerious mental illnessSubstance use disordersMental illnessSubstance useUse disordersAdditional clinical benefitFactorial repeated-measures analysisSevere mental illnessHomeless personsCase management servicesStructured behavioral interventionsSubstance abuse outcomesRepresentative payeeRepeated-measures analysisClinical benefitPublic support paymentsAbused substancesDual diagnosisCommunity careSubstance abuseBehavioral interventionsIllnessAbuse outcomesClient subgroupsGreater improvement